TrialHaematologica2019

Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.

Julia Stomper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.